Alzheimer’s Imaging Drug Shows Promise

WASHINGTON — A federal panel of medical experts said Thursday a first-of-a-kind imaging chemical designed to help screen for Alzheimer’s disease could be useful pending additional study and training for physicians.The Food and Drug Adminis…

WASHINGTON — A federal panel of medical experts said Thursday a first-of-a-kind imaging chemical designed to help screen for Alzheimer’s disease could be useful pending additional study and training for physicians.

The Food and Drug Administration panel of advisers voted 16-0 in favor of approval for Eli Lilly’s Amyvid on the condition that the company demonstrates the images can be consistently interpreted by physicians who have received training in reading the scans.

Read More…
More on Alzheimer’s